News on DT Industries from BioPortfolio.com http://www.BioPortfolio.com Consolidated DT Industries news from BioPortfolio.com Wed, 10 Feb 2010 13:20:43 GMT en Cold ischemia in microvascular breast reconstructionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041710&HITNO=0&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041710&THISHREF=http://c.moreover.com/click/here.pl%3fz2539211871%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041710&HITNO=0&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041710&THISHREF=http://c.moreover.com/click/here.pl%3fz2539211871%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: The Impact of Income and Education on Dietary Habits in Stone Formershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034273&HITNO=1&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034273&THISHREF=http://c.moreover.com/click/here.pl%3fz2535694834%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034273&HITNO=1&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034273&THISHREF=http://c.moreover.com/click/here.pl%3fz2535694834%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Stem Cell Research - Data from D.T. Fox et al provide new insights into stem cell researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026502&HITNO=2&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026502&THISHREF=http://c.moreover.com/click/here.pl%3fz2530923308%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026502&HITNO=2&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026502&THISHREF=http://c.moreover.com/click/here.pl%3fz2530923308%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Movie tells story of father's fight to cure muscle-wasting diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003493&HITNO=3&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003493&THISHREF=http://c.moreover.com/click/here.pl%3fz2519538424%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003493&HITNO=3&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003493&THISHREF=http://c.moreover.com/click/here.pl%3fz2519538424%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKTUU: Missing the Signshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995725&HITNO=4&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995725&THISHREF=http://c.moreover.com/click/here.pl%3fz2515851264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995725&HITNO=4&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995725&THISHREF=http://c.moreover.com/click/here.pl%3fz2515851264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAdvance for Nurses: Thoratec reports revenues of $373.9M for fiscal 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981195&HITNO=5&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981195&THISHREF=http://c.moreover.com/click/here.pl%3fz2506848323%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981195&HITNO=5&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981195&THISHREF=http://c.moreover.com/click/here.pl%3fz2506848323%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980913&HITNO=6&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980913&THISHREF=http://c.moreover.com/click/here.pl%3fz2506651953%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980913&HITNO=6&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980913&THISHREF=http://c.moreover.com/click/here.pl%3fz2506651953%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Arthroscopy as a treatment for knee osteoarthritishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981795&HITNO=7&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981795&THISHREF=http://c.moreover.com/click/here.pl%3fz2507199126%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981795&HITNO=7&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981795&THISHREF=http://c.moreover.com/click/here.pl%3fz2507199126%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: US FDA approval for Thoratec's HeartMate II for destination therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970017&HITNO=8&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970017&THISHREF=http://c.moreover.com/click/here.pl%3fz2501116999%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3970017&HITNO=8&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3970017&THISHREF=http://c.moreover.com/click/here.pl%3fz2501116999%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955365&HITNO=9&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955365&THISHREF=http://c.moreover.com/click/here.pl%3fz2493986526%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3955365&HITNO=9&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3955365&THISHREF=http://c.moreover.com/click/here.pl%3fz2493986526%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDotmed: Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954192&HITNO=10&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954192&THISHREF=http://c.moreover.com/click/here.pl%3fz2492552896%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954192&HITNO=10&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954192&THISHREF=http://c.moreover.com/click/here.pl%3fz2492552896%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3939518&HITNO=11&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3939518&THISHREF=http://c.moreover.com/click/here.pl%3fz2484668317%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3939518&HITNO=11&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3939518&THISHREF=http://c.moreover.com/click/here.pl%3fz2484668317%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: FDA approves Thoratec's HeartMate II LVAS for DThttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3940046&HITNO=12&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3940046&THISHREF=http://c.moreover.com/click/here.pl%3fz2484890531%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3940046&HITNO=12&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3940046&THISHREF=http://c.moreover.com/click/here.pl%3fz2484890531%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3939067&HITNO=13&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3939067&THISHREF=http://c.moreover.com/click/here.pl%3fz2484399076%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3939067&HITNO=13&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3939067&THISHREF=http://c.moreover.com/click/here.pl%3fz2484399076%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3937577&HITNO=14&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3937577&THISHREF=http://c.moreover.com/click/here.pl%3fz2483574929%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3937577&HITNO=14&MSIZE=78&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=DT%20Industries&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3937577&THISHREF=http://c.moreover.com/click/here.pl%3fz2483574929%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: